Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials

Biometrics

Volumn 64, Issue 4, 2008, Pages 1247-1255

  Li, Zhiguo ^a   Gilbert, Peter ^b   Nan, Bin ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b USA   (United States)

Author keywords

Case cohort design; HIV vaccine trial; Interval censoring; Proportional hazards model; Random dropout; Weighted likelihood

Indexed keywords

DIAGNOSIS; IMMUNE SYSTEM; INVERSE PROBLEMS; SAMPLING;

CASE-COHORT DESIGN; COHORT DESIGN; COVARIATES; HIV INFECTION; HIV VACCINE TRIAL; INTERVAL CENSORING; PROPORTIONAL HAZARD MODELS; RANDOM DROPOUT; WEIGHTED LIKELIHOOD; WEIGHTED LIKELIHOOD METHOD;

VACCINES;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

COHORT ANALYSIS; HAZARD ASSESSMENT; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; NUMERICAL MODEL; SURVIVAL; VACCINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MATHEMATICAL MODEL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL MODEL; SURVIVAL;

EID: 56049092339     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2008.00998.x     Document Type: Article

References (17)

1. Borgan, O., Langholz, B., Samuelsen, S. O., Goldstein, L., and Pogoda, J. (2000). Exposure stratified case-cohort designs. Lifetime Data Analysis 6, 39 58.
2. Breslow, N. E. and Wellner, J. A. (2007). Weighted likelihood for semiparametric models and two-phase stratified samples, with application to Cox regression. Scandinavian Journal of Statistics 34, 86 102.
3. Cox, D. R. (1972). Regression models and life-tables (with discussion). Journal of the Royal Statistical Society, Series B 34, 187 220.
4. Cox, D. R. (1975). Partial likelihood. Biometrika 62, 269 276.
5. Finkelstein, D. M. (1986). A proportional hazards model for interval-censored failure time data. Biometrics 42, 845 854.
6. Flynn, N. M., Forthal, D. N., Harro, C. D., Judson, F. N., Mayer, K. H., Para, M. F., and the rgp 120 HIV Vaccine Study Group 2005). Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. Journal of Infectious Diseases 191, 654 665.
7. Forthal, D. N., Gilbert, P. B., Landucci, G., and Phan, T. (2007). Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate. Journal of Immunology 178, 6596 6603.
8. Gilbert, P. B., et al 2005). Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. Journal of Infectious Diseases 191, 666 677.
9. Kalbfleisch, J. D. and Prentice, R. L. (1973). Marginal likelihoods based on Cox's regression and life model. Biometrika 60, 267 278.
10. Kalbfleisch, J. D. and Prentice, R. L. (2002). The Statistical Analysis of Failure Time Data. New York : Wiley.
11. Kulich, M. and Lin, D. Y. (2004). Improving efficiency of relative-risk estimation in case-cohort studies. Journal of the American Statistical Association 99, 832 844.
12. Little, R. J. A. and Rubin, D. B. (2002). Statistical Analysis with Missing Data, 2nd edition. New York : Wiley.
13. Manski, C. F. and Lerman, S. R. (1977). The estimation of choice probabilities from choice based samples. Econometrika 45, 1977 1988.
14. Prentice, R. L. (1986). A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73, 1 11.
15. Prentice, R. L. and Gloeckler, L. A. (1978). Regression analysis of grouped survival data with application to breast cancer data. Biometrics 34, 57 67.
16. Robins, J. M., Rotnitzky, A., and Zhao, L. P. (1994). Estimation of regression coefficients when some regressors are not always observed. Journal of the American Statistical Association 89, 846 866.
17. Self, S. G. and Prentice, R. L. (1988). Asymptotic distribution theory and efficiency results for case-cohort studies. Annals of Statistics 16, 64 81.